Intestinal Diseases  >>  Colal-Pred (prednisolone metasulfobenzoate sodium)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Colal-Pred (prednisolone metasulfobenzoate sodium) / Norgine, Alizyme, Merck (MSD)
NCT00299013 / 2004-005032-35: Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis

Completed
3
796
Europe, RoW
COLAL-PRED®, Prednisolone sodium metasulfobenzoate., Prednisolone
Alizyme
Ulcerative Colitis
04/08
04/08

Download Options